Seka Lazare, Ph.D.
Associate Director, Next Generation Sequencing
Seka Lazare is associate director, next generation sequencing at Verve Therapeutics. Her expertise is in next generation sequencing technology and its application in human genetic research. Prior to joining Verve, she worked as a scientific manager at Illumina Inc., where she led multiple groups focused on optimizing and executing NGS and related workflows. She holds a BSc. in Genetics from University College London and obtained her Ph.D., from the European Research Institute for the Biology of Ageing (University of Groningen). Her Ph.D. work explored the molecular changes in blood stem cells as they age, uncovering a robust transcriptomic signature of aged hematopoietic stem cells.